Minidose gonadotropin-releasing hormone agonist is the treatment of choice in poor responders with high follicle-stimulating hormone levels. (Q49094012)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8034083%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

title

Minidose gonadotropin-releasing hormone agonist is the treatment of choice in poor responders with high follicle-stimulating hormone levels (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8034083%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

author name string

D Feldberg

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8034083%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

J Farhi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8034083%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

J Ashkenazi

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8034083%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

D Dicker

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8034083%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

J Shalev

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8034083%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

Z Ben-Rafael

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8034083%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

language of work or name

English

0 references

publication date

1 August 1994

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8034083%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

number of pages

4

1 reference

based on heuristic

inferred from page(s)

published in

Fertility and Sterility

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8034083%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

volume

62

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8034083%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8034083%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

page(s)

343-346

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8034083%20AND%20SRC:MED&resulttype=core&format=json

Predictive value of hormonal profiles before stimulation for in vitro fertilization

23 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2956889-7

The predictive value and the management of cycles with low initial estradiol levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2956889-7

Ovarian hyporesponsiveness in combined gonadotropin-releasing hormone agonist and menotropin therapy is associated with low serum follicle-stimulating hormone levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2956889-7

Induction of luteolysis by luteinizing hormone-releasing factor (LRF) agonist: sensitivity, reproducibility, and reversibility

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2956889-7

Specific binding of luteinizing hormone releasing hormone to human luteal tissue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2956889-7

Outcome of in vitro fertilization in women with low response to ovarian stimulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2956889-7

Gonadotropin-releasing hormone agonist-induced ovarian hyperstimulation: low-dose side effects in women and monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2956889-7

Value of suppression with a gonadotropin-releasing hormone agonist prior to gonadotropin stimulation for in vitro fertilization.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2956889-7

Adjuvant leuprolide in normal, abnormal, and poor responders to controlled ovarian hyperstimulation for in vitro fertilization/gamete intrafallopian transfer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2956889-7

Improved pregnancy outcome with gonadotropin releasing hormone agonist (GnRH-a) stimulation is due to the improvement in oocyte quantity rather than quality

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2956889-7

An alternate approach to controlled ovarian hyperstimulation in "poor responders": pretreatment with a gonadotropin-releasing hormone analog.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2956889-7

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0015-0282(16)56889-7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8034083%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

1 reference